e-learning
resources
Milan 2017
Wednesday, 13.09.2017
From the bench: therapeutic approaches in COPD and emphysema
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Propolis reverts cigarette smoke-induced emphysema through macrophage alternative activation
M. Lanzetti Daher de Deus (Niteroi/Rj, Brazil)
Source:
International Congress 2017 – From the bench: therapeutic approaches in COPD and emphysema
Session:
From the bench: therapeutic approaches in COPD and emphysema
Session type:
Poster Discussion
Number:
4937
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Lanzetti Daher de Deus (Niteroi/Rj, Brazil). Propolis reverts cigarette smoke-induced emphysema through macrophage alternative activation. 4937
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
ATRvD1 reverts cigarette smoke-induced emphysema by pro-resolutive and antioxidant effects
Source: International Congress 2017 – From the bench: therapeutic approaches in COPD and emphysema
Year: 2017
Cigarette smoke-induced emphysema occurs in the absence of TLR4-signalling in a murine model of COPD
Source: Annual Congress 2008 - Best of lung epithelial cells 2008
Year: 2008
Mitochondria-targeted H2S suppresses and reverses cigarette smoke-induced inflammasome activity and lung injury in experimental COPD
Source: ERS Lung Science Conference 2020
Year: 2020
Ceramide-1-phosphate inhibits cigarette smoke-induced airway inflammation
Source: Eur Respir J 2015; 45: 1669-1680
Year: 2015
Role of activin-A in cigarette smoke-induced inflammation and COPD
Source: Eur Respir J 2014; 43: 1028-1041
Year: 2014
The role of microRNA-155 in cigarette smoke-induced inflammation.
Source: International Congress 2018 – New kids on the block: novel molecular pathways and therapeutic targets in chronic lung diseases
Year: 2018
Cryptotanshinone attenuates airway Inflammation induced by cigarette smoke in mice
Source: International Congress 2016 – New signalling pathways in COPD
Year: 2016
Ablation of ADAM17 protects against cigarette smoke-induced emphysema in mice
Source: International Congress 2019 – Effects of environmental exposures in lung pathology and the underlying mechanisms
Year: 2019
A neutrophil elastase inhibitor reduces cigarette smoke-induced remodelling of lung vessels
Source: Eur Respir J 2003; 22: 77-81
Year: 2003
Involvement of NCOA4-mediated ferritinophagy in cigarette smoke-induced ferroptosis in COPD pathogenesis
Source: International Congress 2018 – New kids on the block: novel molecular pathways and therapeutic targets in chronic lung diseases
Year: 2018
Role of ß2-adrenergic receptor in cigarette smoke-induced COPD in mice
Source: International Congress 2018 – Functional genomics and COPD: new challenges
Year: 2018
P2RX4 signalling enhances acute cigarette smoke-induced lung inflammation and chronic lung emphysema development
Source: International Congress 2019 – Airway inflammation: pharmacological mechanisms and novel targets
Year: 2019
PDE4 inhibition prevents corticosteroid-resistant lung inflammation induced by cigarette smoke exposure in mice
Source: Annual Congress 2009 - Highlighting the epithelial cell in lung disease: from COPD to cancer to acute lung injury
Year: 2009
TRPA1 mediates cigarette smoke-induced TNFa secretion in macrophages
Source: Virtual Congress 2021 – Environmental and lifestyle impacts on chronic lung disease
Year: 2021
Neu-164, a novel antioxidant and anti-inflammatory compound, reduces cigarette smoke-induced lung inflammation
Source: Annual Congress 2008 - COPD
Year: 2008
Tiotropium inhalation prevents acute cigarette smoke-induced airway inflammation in mice
Source: Annual Congress 2009 - Airway inflammation and host defence
Year: 2009
Quercetin attenuates inflammation in cigarette smoke stimulated airway epithelial cells: Possible involvement of autophagy
Source: Annual Congress 2013 –New drugs in respiratory medicine
Year: 2013
Deficiency in neutrophil serine proteases protects mice from the development of cigarette smoke-induced emphysema
Source: Annual Congress 2010 - Proteases and the matrix
Year: 2010
Murine lung airway fibroblasts drive fibrosis through STAT4 signaling after cigarette smoke exposure
Source: Annual Congress 2012 - The smoking gun in COPD biology
Year: 2012
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept